Expression of growth factor receptors is not a prognostic indicator in young patients with colorectal cancer

Journal of the Royal College of Surgeons of Edinburgh

Volumn 42, Issue 2, 1997, Pages 98-101

  Langlois, N ^a   Walker, L G ^a   Smith, I ^a   Skinner, L ^a   Eremin, O ^a   Heys, S D ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Colorectal cancer; Growth factors; Young patients

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; CANCER STAGING; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROGNOSIS; RECEPTOR UPREGULATION; SURVIVAL;

COLON; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, GROWTH FACTOR; RECTUM; SCOTLAND; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030895612     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Anon. Office of Population Censuses and Surveys. Cancer Research Campaign: Cancer Statistics. Incidence, Survival and Mortality in England and Wales. Studies on Medical and Population Subjects No. 43. London: HMSO, 1981: viii, xii, 22-9.
2. Anon. Cancer Service in Scotland. Scottish Home and Health Department, 1979: 60-73.
3. Heys SD, O'Hanrahan TJ, Brittenden J, Eremin O. Colorectal cancer in young patients: a review of die literature. Eur J Surg Oncol 1994; 20: 225-31.
4. Umpleby HC, Bristol JB, Ranney JB, Williamson RCN. Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum 1984; 27: 803-10.
5. McDermott FT et al. Changing survival prospects in rectal carcinoma-a series of 1,306 patients managed by one surgeon. Dis Colon Rectum 1986; 29: 798-803.
6. Heys SD, Sherif A, Bagley JS, Brittenden J, Smart C, Eremin O. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg 1994; 81: 685-8.
7. Murthy U, Anzano MA, Greig R. Expression of TGF-α, EGF and TGF-β receptors in human colon carcinoma cell lines. Int J Cancer 1989; 44: 110-5.
8. Steele CM. Peptide regulatory factors and malignancy. Lancet 1989; 2(8653): 30-5.
9. Sporn MB, Roberts AB, Wakefield LM, de Crombugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 1987; 105: 1039-45.
10. McCann A et al. C-erbB-2 protein expression in primary human tumours. Cancer 1990; 65: 88-92.
11. Steele RJC, Kelly P, Ellul B, Eremin O. Epidermal growth factor receptor expression in colorectal cancer. Br J Cancer 1990; 77: 1352-4.
12. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-8.
13. Langlois NEI, King G, Herriot R, Thompson WD. Non-enzymatic retrieval of antigen permits staining of follicle centre cells by the rabbit polyclonal antibody to protein gene product 9.5. J Pathol 1994; 173: 249-53.
14. Van Noorden S. Tissue preparation and immunological staining techniques for light microscopy. In: Polak J, Van Noorden S, eds. Immunocytochemistry: Modern Methods and Applications, 2nd edn. Bristol: Wright, 1986: 26-53.
15. Mantel N. Evaluation of survival data and two new rank statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
16. Cox DK. Regression models and life tables (with discussion). J R Stat Soc GB 1972; 34: 187-220.
17. Christensen E. Multivariate survival analysis using Cox's regression model. Hepatology 1987; 7: 1346-58.
18. Hermanek P, Sobin LH. TNM. Classification of Malignant Tumours. Berlin: Springer, 1987: 47-9.
19. Cohen S. The epidermal growth factor (EGF). Cancer 1983; 53: 1787-91.
20. Malo C, Ménard D. Influence of epidermal growth factor on the development of suckling mouse intestinal mucosa. Gastroenterology 1982; 83: 28-35.
21. Mayer AM, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993; 71: 2454-60.
22. Coussens L et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985; 230: 1132-9.
23. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of the human c-erbB-2 gene: a 185 kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232: 1644-6.
24. Perren TJ. C-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer 1991; 63: 328-32.
25. Uchino S et al. Overexpression of c-erbB-2 protein in gastric cancer. Cancer 1993; 72: 3179-84.
26. D'Emilia J, Bukovas K, D'Ercole K, Wolf B, Steele G, Summerhayes IC. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression of the colon. Oncogene 1989; 4: 1233-9.
27. Cheifetz S et al. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 1987; 48: 409-15.
28. Hoosein NM et al. Differential sensitivity of subclasses of human colon carcinoma cell lines to growth inhibitory effects of transforming growth factor-β1. Exp Cell Res 1989; 181: 442-53.
29. Kimichi A, Wang X-F, Weinberg RA, Cheifetz S, Massagué J. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 1988; 240: 196-9.
30. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature 1988; 332: 217-9.